01 4Gowling Lafleur Henderson LLP
02 1Gowling WLG (Canada) LLP
03 2Hoffmann-La Roche Limited
01 21340588
02 22030433
03 22224125
04 12531486
01 7Saquinavir Mesylate
01 3Capsule
02 4Tablet
01 22010-11-21
02 22016-06-04
03 22016-06-08
04 12024-07-05
Patent Expiration Date : 2010-11-21
Date Granted : 1997-10-21
Brand Name : INVIRASE
Patent Number : 2030433
Filing Date : 1990-11-21
Strength per Unit : 500mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2010-11-21
Date Granted : 1997-10-21
Patent Expiration Date : 2010-11-21
Date Granted : 1997-10-21
Brand Name : INVIRASE
Patent Number : 2030433
Filing Date : 1990-11-21
Strength per Unit : 200mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2010-11-21
Date Granted : 1997-10-21
Patent Expiration Date : 2016-06-04
Date Granted : 2004-09-28
Brand Name : INVIRASE
Patent Number : 2224125
Filing Date : 1996-06-04
Strength per Unit : 200mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-06-04
Date Granted : 2004-09-28
Patent Expiration Date : 2016-06-04
Date Granted : 2004-09-28
Brand Name : INVIRASE
Patent Number : 2224125
Filing Date : 1996-06-04
Strength per Unit : 500mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-06-04
Date Granted : 2004-09-28
Patent Expiration Date : 2016-06-08
Date Granted : 1999-06-08
Brand Name : INVIRASE
Patent Number : 1340588
Filing Date : 1989-06-01
Strength per Unit : 500mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-06-08
Date Granted : 1999-06-08
Patent Expiration Date : 2016-06-08
Date Granted : 1999-06-08
Brand Name : INVIRASE
Patent Number : 1340588
Filing Date : 1989-06-01
Strength per Unit : 200mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-06-08
Date Granted : 1999-06-08
Patent Expiration Date : 2024-07-05
Date Granted : 2012-10-02
Brand Name : INVIRASE
Patent Number : 2531486
Filing Date : 2004-07-05
Strength per Unit : 500mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-07-05
Date Granted : 2012-10-02
